Oxymorphone Hydrochloride
Product Images NDC 63304-221

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxymorphone Hydrochloride (NDC 63304-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ranbaxy Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5 mg (5mgcarton)

Label for Oxymorphone hydrochloride extended-release tablets 5 mg by Ranbaxy Pharmaceuticals Inc. The label indicates a twice-a-day (every 12 hours) dosing schedule, with 30 tablets per package. It includes warnings about swallowing tablets whole and storage instructions, plus a barcode and NDC 63304-218-30.*

FDA Label Image

Figure 1 (Figure1)

A line graph comparing the percentage of patients improved versus the percent reduction or improvement in pain for Oxymorphone ER and placebo groups. The y-axis represents the percentage of patients improved, and the x-axis shows the percent reduction or improvement in pain. Oxymorphone ER shows a higher percentage of patients improved than placebo across multiple pain improvement levels.*

FDA Label Image

Figure 2 (Figure2)

A line graph comparing the percentage of patients improved versus the percent of reduction or improvement in pain for Oxymorphone ER and placebo. The x-axis represents percent reduction/improvement in pain (from >0 to 100%), and the y-axis shows the percentage of patients improved (0 to 100%). Oxymorphone ER shows consistently higher percentages of patient improvement across all pain reduction levels compared to placebo.*

FDA Label Image

Structure (Image 01)

Chemical structure diagram of Oxymorphone hydrochloride showing its molecular arrangement, including hydroxyl groups, a methylated nitrogen, and ketone groups as part of the compound's structure.*

FDA Label Image

40 mg (Image 02)

Label for Oxymorphone hydrochloride extended-release tablets 40 mg by Ranbaxy Pharmaceuticals Inc. The label indicates the product is to be taken twice daily (every 12 hours) and comes in a package of 30 tablets. The label includes dosage instructions, storage information, a barcode, and a note that the medication guide should be dispensed to each patient.*

FDA Label Image

7.5 mg (Image 03)

Label for Oxymorphone Hydrochloride extended-release tablets by Ranbaxy Pharmaceuticals Inc. Each tablet contains 7.5 mg of active ingredient. The packaging indicates a dosing interval of twice daily (every 12 hours) with 30 tablets per container. The label includes usage instructions, storage information, and a barcode.*

FDA Label Image

10 mg (Image 04)

Label for Oxymorphone Hydrochloride Extended-Release Tablets, 10 mg strength, by Ranbaxy Pharmaceuticals Inc. The label indicates a twice-a-day dosing schedule with 30 tablets per bottle. It includes dosage instructions, storage information, and a barcode. The label also mentions the product is Rx only and highlights the presence of a medication guide inside.*

FDA Label Image

15 mg (Image 05)

Label for Oxymorphone hydrochloride extended-release tablets, 15 mg strength, by Ranbaxy Pharmaceuticals Inc. The label specifies a twice-a-day dosage every 12 hours and includes medication guide dispensing instructions. The package contains 30 tablets. Additional details include storage instructions and handling precautions.*

FDA Label Image

20 mg (Image 06)

Label for Oxymorphone hydrochloride extended-release tablets 20 mg by Ranbaxy Pharmaceuticals Inc. The label indicates twice-a-day dosing every 12 hours, includes a medication guide, and specifies a package count of 30 tablets. It also includes directions for swallowing tablets whole and storage instructions. The label shows the NDC 63304-222-30 and barcode.*

FDA Label Image

30 mg (Image 07)

Label for Oxymorphone hydrochloride extended-release tablets, 30 mg strength, manufactured by Ranbaxy Pharmaceuticals Inc. The label indicates a twice-a-day (every 12 hours) dosing schedule and includes the quantity of 30 tablets in the package. It also highlights that each tablet contains 30 mg of oxymorphone and includes dispensing instructions and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.